Search results
COVID-flu combination vaccine shows positive results in late-stage trial, Moderna says
WISN 12 Milwaukee· 2 hours agoCalling the outcome of the late-stage trial “breakthrough results,” Moderna’s Chief Medical Affairs...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 5 hours agoIt has also initiated multiple phase III studies of its RSV vaccine in adults over 50 years of age...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 8 hours agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
Celebrity doctors promoted Covid vaccine without declaring payments
The Telegraph via Yahoo News· 2 days agoThe pharmaceutical watchdog has been urged to investigate after a string of celebrity doctors took...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
Motley Fool via Yahoo Finance· 2 weeks agoAnd on that basis, it appears that investors will have more to like about AstraZeneca's plans than...
Innovation, Partnerships & Progress: How Life Sciences Is Booming in Maryland’s Montgomery County
FierceBiotech· 6 hours agoFrom the early wave of fast-breaking COVID-19 vaccines developed by Novavax, to the first-ever...
AstraZeneca Gets Workers’ Covid-19 Faith Bias Suit Narrowed
Bloomberg Law· 4 days ago‘s bid to dismiss some claims from workers who asserted religious objections to its Covid-19 vaccination mandate proved successful when a federal court adopted a magistrate judge’s recommendations ...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 1 week agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
Feds plan for smoother access to RSV infant shot
Politico· 2 weeks agoMandy Cohen, don’t want parents to run into roadblocks this coming respiratory illness season when they seek an immunization for babies that protects against respiratory syncytial virus. The ...
AstraZeneca started at buy at Goldman, which rates GSK a neutral
Market Watch· 2 weeks agoGoldman Sachs started coverage of AstraZeneca at buy as it rated rival pharmaceutical company GSK a...
